Copenhagen Stock Loans in Denmark

Nasdaq Copenhagen is the principal cash-equity venue of Denmark. Founded in 1808 (Københavns Fondsbørs); part of Nasdaq Nordic from 2008, it operates under the oversight of Finanstilsynet (Danish FSA), and its leading benchmarks are OMX Copenhagen 25 (OMXC25), OMX Copenhagen All-Share. Listing standards are set out in the Nasdaq Copenhagen Rules for Issuers of Shares.

Copenhagen at a glance:

Historically the Copenhagen Stock Exchange. Distinctively concentrated in pharmaceutical and shipping issuers; Novo Nordisk’s weight in the OMXC25 shapes its single-stock liquidity profile.

On Nasdaq Copenhagen specifically, eligibility turns on where the name sits in the market’s liquidity, which is unusually concentrated. OMXC25 constituents — led by the large pharmaceutical and shipping issuers, with Novo Nordisk alone carrying an outsized weight — hold the free float and daily turnover that support a higher loan-to-value; Large and Mid Cap names on the Main Market are financed on their own merits, while Nasdaq First North Growth Market Denmark and thin small-caps are taken more selectively. Short-selling disclosure follows the EU regime, with net short positions reported to Finanstilsynet, which is a useful read on which lines the market itself treats as liquid.

The principal regulatory reference on Copenhagen is Capital Markets Act Section 38. How it applies to any single transaction — reporting levels, step thresholds — turns on the underlying rules and national-law overlays, which we map against your contemplated transaction at the structuring stage alongside the counsel you appoint.

The citations above are public regulatory references, given for orientation only and not as legal advice. Take independent legal advice in the relevant jurisdiction for any specific transaction.

See the full process →